Effectiveness of a Smoking Cessation Algorithm Integrated Into HIV Primary Care
Completed · Phase 4
Conditions studied: HIV, AIDS, Smoking Cessation
In brief
To determine the efficacy of an algorithm designed to recommend smoking cessation-related pharmacotherapy options to the primary care providers of smokers living with HIV/AIDS.
Key facts
- Study ID
- NCT03670316
- Run by
- University of Alabama at Birmingham
- People needed
- 371
- Starts
- 2020-08-17
- Expected to finish
- 2025-06-30
- Last updated by the study team
- 2026-05-22
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Enrollment in the CNICS clinical cohort.
- 18 years or older;
- Receiving HIV care at the UAB, UW or Fenway Health clinics and not anticipating changing clinics over the next six months
- Smoking greater than or equal to 5 cigarettes per day (cpd) for the past month
- Living in an unrestricted environment that allows smoking.
You may not qualify if…
- Cognitive impairment such that unable to provide informed consent;
- Non-English speaking;
- Acutely suicidal, manic, acutely intoxicated, or otherwise not stable enough to provide informed consent;
- Currently receiving smoking cessation treatment.
Where it is running
- University of Alabama, Birmingham — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.